EVOTAZ 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
EVOTAZ 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
1151025001
Prescription Type
Uso Hospitalario
Authorization Date
Jul 29, 2015
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1151025001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
ATAZANAVIR SULFATOActive
Quantity: 341,70 mg
Name: ATAZANAVIR SULFATO
COBICISTATActive
Quantity: 294,12 mg
Name: COBICISTAT
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR15